Italian researchers found that supplementing ranibizumab treatment with the daily administration of an NSAID solution improved AMD symptoms better than ranibizumab alone, and believe over time greater statistical significance will emerge.
Does adherence to the Mediterranean diet reduce the risk of age-related macular degeneration? Portuguese researchers attempted to determine the AMD-preventative nature of the popular regional diet, which is commonly associated with fish, fruit, grains, and the occasional splash of wine.
Although differences between treatment groups in best-corrected visual acuity were not statistically significant, combination treatment reduced central macular thickness and macular volume statistically significantly more than bevacizumab alone.
A large observational study of results in routine clinical practice showed that visual acuity outcomes 12 months after Aflibercept or Ranibizumab treatment did not differ, and neither did the number of injections required for each agent.
The only factor that predicted visual outcomes one year after nAMD diagnosis was baseline visual acuity, which maintained its predictive ability five years after diagnosis. Visual acuity increased more frequently in women.